InsiderClue
← All stocks

Nurix Therapeutics, Inc.

NRIX Scheduled selling only
CIK 0001549595 #1793 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.53M
$1.35M on a plan · $3.18M straight out of an exercise
Sold at will
$0.00
0 of 40 sales
Net
−$4.53M
$0.00 against sales at will

By person

4 insiders · 42 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ring Christine
Chief Legal Officer
—
$3.26M (20) scheduled
−$3.26M
9,110
0.0088%
$242.67K
−63.0%
van Houte Hans
Chief Financial Officer
—
$635.33K (10) scheduled
−$635.33K
40,166
0.0387%
$1.07M
+29.6%
Hansen Gwenn
Chief Scientific Officer
—
$630.90K (10) scheduled
−$630.90K
117,227
0.1130%
$3.12M
+159.6%
GREGORY JULIA P
Director
—
—
—
10,750
0.0104%
$286.35K
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Hansen Gwenn
3 Feb 2026
Chief Scientific Officer
Exercised, kept
31,333
$0.84
$26.32K
GREGORY JULIA P
17 Sep 2025
Director
Exercised, kept
10,750
$1.86
$20.00K
Show all 42 transactions →

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 27
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 272,001
History held since 29 Jul 2020